Trust celebrates ranking second for ovarian cancer survival rates

Somerset has ranked second in England for ovarian cancer survival rates, according to an NHS England report.

(c) Somerset NHS Foundation Trust

(c) Somerset NHS Foundation Trust

The latest National Ovarian Cancer Audit taken in 2021 shows 77% of those with ovarian cancer are surviving at least one year after their diagnosis in the county, with only Barts Health NHS Trust ranking higher.

Jo Morrison, a gynaecological-oncology consultant at Somerset NHS Foundation Trust, said: ‘To come second in the country for ovarian cancer survival rates is an incredible achievement. Our 12-month survival rates are similar to those in the best-performing countries internationally, such as Norway and Denmark.'

The National Ovarian Cancer Audit was launched following concerns cancer survival rates in the UK weren't as good as in other countries in Europe.

Barts finished in first place for one-year survival rates in the audit and topped five-year survival rates in 2023.

The work was originally driven by clinicians and patient support groups who wanted to improve outcomes through understanding of why there was so much variation across the country.

Morrison added: ‘Thanks to the support of the British Gynaecological Cancer Society and the ovarian cancer charities, we contributed to a national pilot audit, which demonstrated big differences between centres across the UK.

‘This national audit has now been adopted by the NHS, through the National Cancer Audit Collaborating Centre, so it will continue long-term.'

NHS rolls out 'trojan horse' therapy for blood cancer patients

NHS rolls out 'trojan horse' therapy for blood cancer patients

By Lee Peart 13 June 2025

A ‘trojan horse’ therapy for blood cancer patients is being rolled out by the NHS in England in a ‘world first’.

Guy's and St Thomas' collaborates with leading AI companies

By Liz Wells 11 June 2025

Guy’s and St Thomas’ NHS Foundation Trust has partnered with leading AI companies to launch the Proactive & Accessible Transformation of Healthcare (PATH) in...

NHS red tape blitz delivers new cancer treatment

By Liz Wells 11 June 2025

NHS patients will be the first in Europe to benefit from a non-invasive liver cancer treatment, as the Government slashes red tape and drives innovation.


Popular articles by Lee Peart